Przybylowski Colin J, Hendricks Benjamin K, Furey Charuta G, DiDomenico Joseph D, Porter Randall W, Sanai Nader, Almefty Kaith K, Little Andrew S
Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States.
J Neurol Surg B Skull Base. 2021 Sep 9;83(Suppl 2):e530-e536. doi: 10.1055/s-0041-1733974. eCollection 2022 Jun.
This study investigated the impact of residual tumor volume (RTV) on tumor progression after subtotal resection and observation of WHO grade I skull base meningiomas. This study is a retrospective volumetric analysis. This study was conducted at a single institution. Patients who underwent subtotal resection of a WHO grade I skull base meningioma and postsurgical observation (July 1, 2007-July 1, 2017). The main outcome was radiographic tumor progression. Sixty patients with residual skull base meningiomas were analyzed. The median (interquartile range) RTV was 1.3 (5.3) cm . Tumor progression occurred in 23 patients (38.3%) at a mean duration of 28.6 months postsurgery. The 1-, 3-, and 5-year actuarial progression-free survival (PFS) rates were 98.3, 58.6, and 48.7%, respectively. The Cox multivariate analysis identified increasing RTV ( = 0.01) and history of more than 1 previous surgery ( = 0.03) as independent predictors of tumor progression. In a Kaplan-Meier analysis for PFS, the RTV threshold of 3 cm maximized log-rank testing significance between groups of patients dichotomized at 0.5 cm thresholds ( < 0.01). The 3-year actuarial PFS rates for meningiomas with RTV ≤3 cm and >3 cm were 76.2 and 32.1%, respectively. When RTV >3 cm was entered as a covariate in the Cox model, it was the only factor independently associated with tumor progression ( < 0.01). RTV was associated with tumor progression after subtotal resection of WHO grade I skull base meningioma in this cohort. An RTV threshold of 3 cm was identified that minimized progression of the residual tumor when gross total resection was not safe or feasible.
本研究调查了残余肿瘤体积(RTV)对世界卫生组织(WHO)I级颅底脑膜瘤次全切除术后观察期间肿瘤进展的影响。本研究为回顾性体积分析。本研究在单一机构开展。纳入2007年7月1日至2017年7月1日期间接受WHO I级颅底脑膜瘤次全切除术并术后观察的患者。主要结局为影像学肿瘤进展。分析了60例残余颅底脑膜瘤患者。RTV的中位数(四分位间距)为1.3(5.3)cm³。23例患者(38.3%)出现肿瘤进展,平均发生于术后28.6个月。1年、3年和5年的无进展生存率(PFS)精算率分别为98.3%、58.6%和48.7%。Cox多因素分析确定RTV增加(P = 0.01)和既往手术次数超过1次(P = 0.03)为肿瘤进展的独立预测因素。在PFS的Kaplan-Meier分析中,以0.5 cm³为阈值将患者分为两组,3 cm³的RTV阈值使组间对数秩检验的显著性最大化(P < 0.01)。RTV≤3 cm³和>3 cm³的脑膜瘤患者其3年PFS精算率分别为76.2%和32.1%。当RTV>3 cm³作为协变量纳入Cox模型时,它是与肿瘤进展独立相关的唯一因素(P < 0.01)。在该队列中,RTV与WHO I级颅底脑膜瘤次全切除术后的肿瘤进展相关。确定了一个3 cm³的RTV阈值,当全切除不安全或不可行时,该阈值可使残余肿瘤的进展最小化。